HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamics.

Abstract
Emerging evidence reveals that prion-like structures play important roles to maintain the well-being of cells. Although self-assembly of small molecules also affords prion-like nanofibrils (PriSM), little is known about the functions and mechanisms of PriSM. Previous works demonstrated that PriSM formed by a dipeptide derivative selectively inhibiting the growth of glioblastoma cells over neuronal cells and effectively inhibiting xenograft tumor in animal models. Here we examine the protein targets, the internalization, and the cytotoxicity pathway of the PriSM. The results show that the PriSM selectively accumulate in cancer cells via macropinocytosis to impede the dynamics of cytoskeletal filaments via promiscuous interactions with cytoskeletal proteins, thus inducing apoptosis. Intriguingly, Tau proteins are able to alleviate the effect of the PriSM, thus protecting neuronal cells. This work illustrates PriSM as a new paradigm for developing polypharmacological agents that promiscuously interact with multiple proteins yet result in a primary phenotype, such as cancer inhibition.
AuthorsYi Kuang, Marcus J C Long, Jie Zhou, Junfeng Shi, Yuan Gao, Chen Xu, Lizbeth Hedstrom, Bing Xu
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 289 Issue 42 Pg. 29208-18 (Oct 17 2014) ISSN: 1083-351X [Electronic] United States
PMID25157102 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Chemical References
  • Antineoplastic Agents
  • Peptides
  • Prions
  • Tubulin
  • tau Proteins
  • Paclitaxel
  • Nocodazole
Topics
  • Antineoplastic Agents (chemistry)
  • Apoptosis
  • Cytoskeleton (metabolism)
  • Endocytosis
  • Glioblastoma (drug therapy)
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • MCF-7 Cells
  • Nanoparticles (chemistry)
  • Nanotechnology
  • Neoplasm Transplantation
  • Neoplasms (metabolism)
  • Nocodazole (chemistry)
  • Paclitaxel (chemistry)
  • Peptides (chemistry)
  • Prions (chemistry)
  • Protein Structure, Tertiary
  • Tubulin (chemistry)
  • tau Proteins (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: